NCT01526330View on ClinicalTrials.gov

Safety, Tolerability and Efficacy of YH14618 in Patients With Degenerative Disc Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

July 31, 2014

Conditions
Degenerative Disc Disease
Interventions
DRUG

YH14618

A mg/disc

DRUG

YH14618

B mg/disc

DRUG

YH14618

C mg/disc

DRUG

Placebo

0mg/disc

Trial Locations (1)

110-746

Kangbuk Samsung Medical Center, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT01526330 - Safety, Tolerability and Efficacy of YH14618 in Patients With Degenerative Disc Disease | Biotech Hunter | Biotech Hunter